首页> 美国卫生研究院文献>other >Parallel microfluidic synthesis of size-tunable polymeric nanoparticles using 3D flow focusing towards in vivo study
【2h】

Parallel microfluidic synthesis of size-tunable polymeric nanoparticles using 3D flow focusing towards in vivo study

机译:使用针对体内研究的3D流动并行微流体合成尺寸可调的聚合物纳米粒子

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。
获取外文期刊封面目录资料

摘要

Microfluidic synthesis of nanoparticles (NPs) can enhance the controllability and reproducibility in physicochemical properties of NPs compared to bulk synthesis methods. However, applications of microfluidic synthesis are typically limited to in vitro studies due to low production rates. Herein, we report the parallelization of NP synthesis by 3D hydrodynamic flow focusing (HFF) using a multilayer microfluidic system to enhance the production rate without losing the advantages of reproducibility, controllability, and robustness. Using parallel 3D HFF, polymeric poly(lactide-co-glycolide)-b-polyethyleneglycol (PLGA-PEG) NPs with sizes tunable in the range of 13–150 nm could be synthesized reproducibly with high production rate. As a proof of concept, we used this system to perform in vivo pharmacokinetic and biodistribution study of small (20 nm diameter) PLGA-PEG NPs that are otherwise difficult to synthesize. Microfluidic parallelization thus enables synthesis of NPs with tunable properties with production rates suitable for both in vitro and in vivo studies.
机译:与本体合成方法相比,纳米粒子(NP)的微流体合成可以增强NPs的理化性质的可控性和可重复性。然而,由于低生产率,微流体合成的应用通常限于体外研究。在本文中,我们报道了使用多层微流体系统通过3D流体动力流聚焦(HFF)进行的NP合成的平行化,以提高生产率,而又不损失可重复性,可控制性和鲁棒性的优点。使用平行3D HFF,可以可重复生产高生产率的聚合聚(丙交酯-乙交酯)-b-聚乙二醇(PLGA-PEG)NP,尺寸可在13-150 nm范围内调节。作为概念的证明,我们使用该系统对原本难以合成的小(直径20 nm)PLGA-PEG NP进行了体内药代动力学和生物分布研究。因此,微流体平行化能够合成具有可调特性的NP,且其生产率适用于体外和体内研究。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号